Global Biopharma Layoffs March 2026LayoffsGlobal Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
Merck Full Year 2025 Financial ReportMerckMerck's 2025 performance shows 1% revenue growth, driven by strong sales of KEYTRUDA, new products like WINREVAIR, and growth in animal health. The company maintains cautious optimism for 2026 amid challenges like patent cliffs and currency fluctuations.
Global Biopharma Layoffs November 2025LayoffsThis article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
Global Biopharma Layoffs September 2025LayoffsThe biopharmaceutical industry sees major september layoffs, with companies like Novartis cutting jobs amid restructurings, trial setbacks, and M&A activity.
Global Biopharma Layoffs August 2025LayoffsThe biopharmaceutical industry sees major August layoffs, with companies like Moderna, Merck cutting jobs amid restructurings, trial setbacks, and M&A activity.
Global Biopharma Layoffs July 2025 LayoffsBiopharmaceutical industry sees major July layoffs, with companies like Sarepta, GSK, Century, and Sage Therapeutics cutting jobs amid restructurings, trial setbacks, and M&A activity.
Merck KGaA Lupus Drug Trial Update: Enpatoran Phase 2 InsightsMerckMerck KGaA reveals detailed results from its phase 2 lupus trial of enpatoran, highlighting mixed outcomes in different patient cohorts and plans to pursue regulatory approval based on promising secondary endpoint data.
Merck Advances Oral PCSK9 Inhibitor with Phase 3 SuccessMerckMerck achieves successful phase 3 trial results for enlicitide, an oral PCSK9 inhibitor, showing significant cholesterol reduction and a strong safety profile, advancing toward potential 2027 approval.
